Literature DB >> 12230617

Clinical oncologists favour radical radiotherapy for localized prostate cancer: a questionnaire survey.

C L Hanna1, M D Mason, J L Donovan, J P Barber.   

Abstract

OBJECTIVE: To explore the treatment preferences of clinical oncologists for managing early prostate cancer and to compare the results with the preferences of urologists.
METHODS: A postal questionnaire survey was conducted of consultant clinical oncologists in the UK.
RESULTS: Consultant clinical oncologists favour radical radiotherapy in most men aged < 70 years, whereas a previous study showed that consultant urologists had a greater preference for radical surgery.
CONCLUSION: There is little consensus about which treatment should be used for managing early prostate cancer. There is an urgent need for results from randomized clinical trials to determine the optimum treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12230617     DOI: 10.1046/j.1464-410x.2002.02970.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  6 in total

1.  Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.

Authors:  Freddie C Hamdy; Jenny L Donovan; J Athene Lane; David E Neal
Journal:  BMJ       Date:  2003-06-28

2.  Presenting treatment options to men with clinically localized prostate cancer: the acceptability of active surveillance/monitoring.

Authors:  Jenny L Donovan
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

3.  Cross-cultural differences in men on active surveillance' anxiety: a longitudinal comparison between Italian and Dutch patients from the Prostate cancer Research International Active Surveillance study.

Authors:  Paola Dordoni; Sebastiaan Remmers; Riccardo Valdagni; Lara Bellardita; Letizia De Luca; Fabio Badenchini; Cristina Marenghi; Monique J Roobol; Lionne D F Venderbos
Journal:  BMC Urol       Date:  2022-07-18       Impact factor: 2.090

4.  Trends in non-metastatic prostate cancer management in the Northern and Yorkshire region of England, 2000-2006.

Authors:  L Fairley; M Baker; J Whiteway; W Cross; D Forman
Journal:  Br J Cancer       Date:  2009-11-10       Impact factor: 7.640

5.  Spatial variation in prostate cancer survival in the Northern and Yorkshire region of England using Bayesian relative survival smoothing.

Authors:  L Fairley; D Forman; R West; S Manda
Journal:  Br J Cancer       Date:  2008-11-04       Impact factor: 7.640

6.  Supportive care needs of men living with prostate cancer in England: a survey.

Authors:  E Ream; A Quennell; L Fincham; S Faithfull; V Khoo; J Wilson-Barnett; A Richardson
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.